" /> Lymphoproliferative syndrome 2 - CISMeF





Preferred Label : Lymphoproliferative syndrome 2;

Symbol : LPFS2;

CISMeF acronym : LPFS2;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Cd27 deficiency;

Description : Lymphoproliferative syndrome-2, also known as CD27 deficiency, is an autosomal recessive immunodeficiency disorder associated with persistent symptomatic EBV viremia, hypogammaglobulinemia, and impairment in specific antibody function resulting from impaired T cell-dependent B-cell responses and T-cell dysfunction (summary by van Montfrans et al., 2012). The phenotype can vary significantly, from asymptomatic borderline-low hypogammaglobulinemia, to a full-blown symptomatic systemic inflammatory response with life-threatening EBV-related complications, including hemophagocytic lymphohistiocytosis, a lymphoproliferative disorder, and malignant lymphoma requiring stem cell transplantation (summary by Salzer et al., 2013). For a discussion of genetic heterogeneity of lymphoproliferative syndrome, see XLP1 (308240).;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the tumor necrosis factor receptor superfamily, member 7 gene (TNFRSF7, 186711.0001);

Neoplasia : Lymphoproliferative disorder (in some patients); Hemophagocytic lymphohistiocytosis (in some patients); Lymphoma (in some patients);

Laboratory abnormalities : Increased susceptibility to EBV infection; Persistent EBV viremia; Decreased fibrinogen (in some patients);

Prefixed ID : #615122;

Details


You can consult :


Nous contacter.
07/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.